The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Oncogenic stress sensed by the immune system: role of natural killer cell receptors
Open accessAbstract
A growing body of research is addressing how pathways that are dysregulated during tumorigenesis are linked to innate immune responses, which can contribute to immune surveillance of cancer. Components of the innate immune system that are localized in tissues are thought to eliminate early neoplastic cells, thereby preventing or delaying the establishment of advanced tumours. This Review addresses our current understanding of the mechanisms that detect cellular stresses that are associated with tumorigenesis and that culminate in the recognition and, in some cases, the elimination of the tumour cells by natural killer cells and other lymphocytes that express natural killer cell receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
Cancer genes and the pathways they control
Vogelstein, B., & Kinzler, K. W. (2004) · Nature Medicine · doi:10.1038/nm1087 · Cited by 4,249
Functions of natural killer cells
Vivier, E., Tomasello, E., Baratin, M., Walzer, T., & Ugolini, S. (2008) · Nature Immunology · doi:10.1038/ni1582 · Cited by 3,943
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
ATM and related protein kinases: safeguarding genome integrity
Shiloh, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1011 · Cited by 2,577
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1782 · Cited by 2,256
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820 · cited 1×
“Activated p19ARF and the DNA damage response can each independently induce the expression of p53 and other mediators that arrest the cell cycle and can lead to cell senescence ( Box 3 ) or apoptosis when persistently activate”
BackgroundKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465 · cited 1×
“Studies show that tumour incidence is higher in p53-deficient mice that are also deficient in IFNγ, the IFNγ receptor and/or STAT1 (Ref”
BackgroundRoles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citationThe DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H. (2005) · Nature · doi:10.1038/nature03884 · Cited by 1,308
Self-citationOncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
Self-citationKILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D.-D., Zhou, J.-Y., Muschel, R., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-141 · Cited by 1,083
Role of the Heat Shock Response and Molecular Chaperones in Oncogenesis and Cell Death
Jolly, C. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1564 · Cited by 1,048
An Activating Immunoreceptor Complex Formed by NKG2D and DAP10
Wu, J., Song, Y., Bakker, A. B. H., Bauer, S., Spies, T., Lanier, L. L., & Phillips, J. H. (1999) · Science · doi:10.1126/science.285.5428.730 · Cited by 1,039
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Groh, V, Bahram, S., Bauer, S., Herman, A., Beauchamp, M., & Spies, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12445 · Cited by 1,017
Regulation of Cutaneous Malignancy by γδ T Cells
Girardi, M., Oppenheim, D. E., Steele, C. R., Lewis, J. M., Glusac, E., Filler, R., Hobby, P., Sutton, B., Tigelaar, R. E., & Hayday, A. C. (2001) · Science · doi:10.1126/science.1063916 · Cited by 1,004
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., & Porgador, A. (2001) · Nature · doi:10.1038/35059110 · Cited by 990
Ghiringhelli, F., Ménard, C., Terme, M., Flament, C., Taieb, J., Chaput, N., Puig, P. E., Novault, S., Escudier, B., Vivier, E., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051511 · Cited by 949
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., & Raulet, D. H. (2000) · Nature Immunology · doi:10.1038/77793 · Cited by 878
Self-citationc-Myc Can Induce DNA Damage, Increase Reactive Oxygen Species, and Mitigate p53 Function
Vafa, O., Wade, M., Kern, S., Beeche, M., Pandita, T. K., Hampton, G. M., & Wahl, G. M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00520-8 · Cited by 876
Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030788 · Cited by 875
Bryceson, Y. T., March, M. E., Ljunggren, H.-G., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 863
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Guerra, N., Tan, Y. X., Joncker, N. T., Choy, A., Gallardo, F., Xiong, N., Knoblaugh, S., Cado, D., Greenberg, N. R., & Raulet, D. H. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.016 · Cited by 850
Self-citationHeat Shock Factor 1 Is a Powerful Multifaceted Modifier of Carcinogenesis
Dai, C., Whitesell, L., Rogers, A. B., & Lindquist, S. (2007) · Cell · doi:10.1016/j.cell.2007.07.020 · Cited by 826
Pende, D., Parolini, S., Pessino, A., Sivori, S., Augugliaro, R., Morelli, L., Marcenaro, E., Accame, L., Malaspina, A., Biassoni, R., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1505 · Cited by 798
Li, H., Han, Y., Guo, Q., Zhang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.240 · Cited by 777
Does the Immune System See Tumors as Foreign or Self?
Pardoll, D. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141135 · Cited by 753
Infections as a major preventable cause of human cancer
Kuper, H., Adami, H. ‐., & Trichopoulos, D. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00742.x · Cited by 740
The role of the unfolded protein response in tumour development: friend or foe?
Ma, Y., & Hendershot, L. M. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1505 · Cited by 710
Retinoic Acid Early Inducible Genes Define a Ligand Family for the Activating NKG2D Receptor in Mice
Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., & Lanier, L. L. (2000) · Immunity · doi:10.1016/s1074-7613(00)80222-8 · Cited by 695
Non-transcriptional control of DNA replication by c-Myc
Dominguez-Sola, D., Ying, C. Y., Grandori, C., Ruggiero, L., Chen, B., Li, M., Galloway, D. A., Gu, W., Gautier, J., & Dalla-Favera, R. (2007) · Nature · doi:10.1038/nature05953 · Cited by 651
The Role of the NKG2D Immunoreceptor in Immune Cell Activation and Natural Killing
Jamieson, A. M., Diefenbach, A., McMahon, C. W., Xiong, N., Carlyle, J. R., & Raulet, D. H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00333-3 · Cited by 647
Self-citationDNAM-1, A Novel Adhesion Molecule Involved in the Cytolytic Function of T Lymphocytes
Shibuya, A., Campbell, D., Hannum, C., Yssel, H., Franz-Bacon, K., McClanahan, T., Kitamura, T., Nicholl, J., Sutherland, G. R., Lanier, L. L., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)70060-4 · Cited by 641
A Role for Skin γδ T Cells in Wound Repair
Jameson, J., Ugarte, K., Chen, N., Yachi, P., Fuchs, E., Boismenu, R., & Havran, W. L. (2002) · Science · doi:10.1126/science.1069639 · Cited by 639
Cretney, E., Takeda, K., Yagita, H., Glaccum, M., Peschon, J. J., & Smyth, M. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.3.1356 · Cited by 616
Cerwenka, A., Baron, J. L., & Lanier, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201238598 · Cited by 606
Pessino, A., Sivori, S., Bottino, C., Malaspina, A., Morelli, L., Moretta, L., Biassoni, R., & Moretta, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.5.953 · Cited by 579
Perforin-Mediated Cytotoxicity Is Critical for Surveillance of Spontaneous Lymphoma
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., MacGregor, D., Godfrey, D. I., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.5.755 · Cited by 576
Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis
Street, S. E. A., Cretney, E., & Smyth, M. J. (2001) · Blood · doi:10.1182/blood.v97.1.192 · Cited by 572
Lee, J.-C., Lee, K.-M., Kim, D.-W., & Heo, D. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.12.7335 · Cited by 549
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
Salih, H. R., Antropius, H., Gieseke, F., Lutz, S. Z., Kanz, L., Rammensee, H.-G., & Steinle, A. (2003) · Blood · doi:10.1182/blood-2003-01-0019 · Cited by 541
Decreased tumor surveillance in perforin-deficient mice.
van den Broek, M. E., Kägi, D., Ossendorp, F., Toes, R., Vamvakas, S., Lutz, W. K., Melief, C. J., Zinkernagel, R. M., & Hengartner, H. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1781 · Cited by 512
Groh, V., Brühl, A., El-Gabalawy, H., Nelson, J. L., & Spies, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1632807100 · Cited by 506
Soriani, A., Zingoni, A., Cerboni, C., Iannitto, M. L., Ricciardi, M. R., Di Gialleonardo, V., Cippitelli, M., Fionda, C., Petrucci, M. T., Guarini, A., et al. (2009) · Blood · doi:10.1182/blood-2008-08-173914 · Cited by 460
Oppenheim, D. E., Roberts, S. J., Clarke, S. L., Filler, R., Lewis, J. M., Tigelaar, R. E., Girardi, M., & Hayday, A. C. (2005) · Nature Immunology · doi:10.1038/ni1239 · Cited by 454
γδ T Cells Provide an Early Source of Interferon γ in Tumor Immunity
Gao, Y., Yang, W., Pan, M., Scully, E., Girardi, M., Augenlicht, L. H., Craft, J., & Yin, Z. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030584 · Cited by 453
Evolutionary struggles between NK cells and viruses
Lanier, L. L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2276 · Cited by 451
Sivori, S., Pende, D., Bottino, C., Marcenaro, E., Pessino, A., Biassoni, R., Moretta, L., & Moretta, A. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199905)29:05<1656::aid-immu1656>3.0.co;2-1 · Cited by 422
Zhu, C., Mills, K. D., Ferguson, D. O., Lee, C., Manis, J., Fleming, J., Gao, Y., Morton, C. C., & Alt, F. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00770-5 · Cited by 421 · cited 1×
“Mutations in tumour suppressor genes, or in components of the pathways that activate tumour suppressors, enable continued cell proliferation of nascent tumour cells but dysregulate DNA replication and repair in a manner that ultimately results in instability of the genome and the accumulation of chromosomal abnormalit…”
BackgroundImmunoregulation in the tissues by γδ T cells
Hayday, A., & Tigelaar, R. (2003) · Nature Reviews Immunology · doi:10.1038/nri1030 · Cited by 414
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Self-citationFunction and regulation of AP-1 subunits in skin physiology and pathology
Angel, P., Szabowski, A., & Schorpp-Kistner, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204380 · Cited by 408
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J., Crowe, N. Y., & Godfrey, D. I. (2001) · International Immunology · doi:10.1093/intimm/13.4.459 · Cited by 379
Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands
Kaiser, B. K., Yim, D., Chow, I.-T., Gonzalez, S., Dai, Z., Mann, H. H., Strong, R. K., Groh, V., & Spies, T. (2007) · Nature · doi:10.1038/nature05768 · Cited by 377
NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma
Smyth, M. J. (2008) · International Immunology · doi:10.1093/intimm/dxn028 · Cited by 377
Tumor-Associated MICA Is Shed by ADAM Proteases
Waldhauer, I., Goehlsdorf, D., Gieseke, F., Weinschenk, T., Wittenbrink, M., Ludwig, A., Stevanovic, S., Rammensee, H.-G., & Steinle, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6768 · Cited by 375
Suppression of Lymphoma and Epithelial Malignancies Effected by Interferon γ
Street, S. E. A., Trapani, J. A., MacGregor, D., & Smyth, M. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020063 · Cited by 375
Pogge von Strandmann, E., Simhadri, V. R., von Tresckow, B., Sasse, S., Reiners, K. S., Hansen, H. P., Rothe, A., Böll, B., Simhadri, V. L., Borchmann, P., et al. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.010 · Cited by 374
Nature's TRAIL—On a Path to Cancer Immunotherapy
Smyth, M. J., Takeda, K., Hayakawa, Y., Peschon, J. J., van den Brink, M. R. M., & Yagita, H. (2003) · Immunity · doi:10.1016/s1074-7613(02)00502-2 · Cited by 366
Gilfillan, S., Chan, C. J., Cella, M., Haynes, N. M., Rapaport, A. S., Boles, K. S., Andrews, D. M., Smyth, M. J., & Colonna, M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081752 · Cited by 361
Crowe, N. Y., Smyth, M. J., & Godfrey, D. I. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020092 · Cited by 352
NKG2D function protects the host from tumor initiation
Smyth, M. J., Swann, J., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 342
Roberts, A. I., Lee, L., Schwarz, E., Groh, V., Spies, T., Ebert, E. C., & Jabri, B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5527 · Cited by 335
Pende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y · Cited by 334
Wu, J. D., Higgins, L. M., Steinle, A., Cosman, D., Haugk, K., & Plymate, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422206 · Cited by 330
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
Doubrovina, E. S., Doubrovin, M. M., Vider, E., Sisson, R. B., O’Reilly, R. J., Dupont, B., & Vyas, Y. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6891 · Cited by 324
El-Sherbiny, Y. M., Meade, J. L., Holmes, T. D., McGonagle, D., Mackie, S. L., Morgan, A. W., Cook, G., Feyler, S., Richards, S. J., Davies, F. E., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4230 · Cited by 321
Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
Stern-Ginossar, N., Gur, C., Biton, M., Horwitz, E., Elboim, M., Stanietsky, N., Mandelboim, M., & Mandelboim, O. (2008) · Nature Immunology · doi:10.1038/ni.1642 · Cited by 315
Retinoids in cancer therapy and chemoprevention: Promise meets resistance
Freemantle, S. J., Spinella, M. J., & Dmitrovsky, E. (2003) · Oncogene · doi:10.1038/sj.onc.1206936 · Cited by 312
Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis
Swann, J. B., Vesely, M. D., Silva, A., Sharkey, J., Akira, S., Schreiber, R. D., & Smyth, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708594105 · Cited by 308
Accelerated tumor growth in mice deficient in DNAM-1 receptor
Iguchi-Manaka, A., Kai, H., Yamashita, Y., Shibata, K., Tahara-Hanaoka, S., Honda, S.-I., Yasui, T., Kikutani, H., Shibuya, K., & Shibuya, A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081611 · Cited by 290
Impairment of NK Cell Function by NKG2D Modulation in NOD Mice
Ogasawara, K., Hamerman, J. A., Hsin, H., Chikuma, S., Bour-Jordan, H., Chen, T., Pertel, T., Carnaud, C., Bluestone, J. A., & Lanier, L. L. (2003) · Immunity · doi:10.1016/s1074-7613(02)00505-8 · Cited by 276
Carayannopoulos, L. N., Naidenko, O. V., Fremont, D. H., & Yokoyama, W. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4079 · Cited by 274
Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells
Street, S. E. A., Hayakawa, Y., Zhan, Y., Lew, A. M., MacGregor, D., Jamieson, A. M., Diefenbach, A., Yagita, H., Godfrey, D. I., & Smyth, M. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031981 · Cited by 264
Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction
Welte, S., Kuttruff, S., Waldhauer, I., & Steinle, A. (2006) · Nature Immunology · doi:10.1038/ni1402 · Cited by 260
Jinushi, M., Vanneman, M., Munshi, N. C., Tai, Y.-T., Prabhala, R. H., Ritz, J., Neuberg, D., Anderson, K. C., Carrasco, D. R., & Dranoff, G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711293105 · Cited by 256
Proteolytic Release of Soluble UL16-Binding Protein 2 from Tumor Cells
Waldhauer, I., & Steinle, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2520 · Cited by 245
Systemic NKG2D Down-Regulation Impairs NK and CD8 T Cell Responses In Vivo
Wiemann, K., Mittrücker, H.-W., Feger, U., Welte, S. A., Yokoyama, W. M., Spies, T., Rammensee, H.-G., & Steinle, A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.2.720 · Cited by 240
Carlsten, M., Björkström, N. K., Norell, H., Bryceson, Y., van Hall, T., Baumann, B. C., Hanson, M., Schedvins, K., Kiessling, R., Ljunggren, H.-G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2264 · Cited by 234
Activation and self‐tolerance of natural killer cells
Gasser, S., & Raulet, D. H. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00460.x · Cited by 233
Self-citationCoudert, J. D., Zimmer, J., Tomasello, E., Cebecauer, M., Colonna, M., Vivier, E., & Held, W. (2005) · Blood · doi:10.1182/blood-2005-03-0918 · Cited by 226
Identification of NKp80, a novel triggering molecule expressed by human NK cells
Vitale, M., Falco, M., Castriconi, R., Parolini, S., Zambello, R., Semenzato, G., Biassoni, R., Bottino, C., Moretta, L., & Moretta, A. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200101)31:1<233::aid-immu233>3.0.co;2-4 · Cited by 223
Diermayr, S., Himmelreich, H., Durovic, B., Mathys-Schneeberger, A., Siegler, U., Langenkamp, U., Hofsteenge, J., Gratwohl, A., Tichelli, A., Paluszewska, M., et al. (2008) · Blood · doi:10.1182/blood-2007-07-101311 · Cited by 220
Eisele, G. (2006) · Brain · doi:10.1093/brain/awl205 · Cited by 219
Lee, K.-M., McNerney, M. E., Stepp, S. E., Mathew, P. A., Schatzle, J. D., Bennett, M., & Kumar, V. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031989 · Cited by 208
ULBP4 is a novel ligand for human NKG2D
Jan Chalupny, N., Sutherland, C. L., Lawrence, W. A., Rein-Weston, A., & Cosman, D. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00714-9 · Cited by 202
MICA/NKG2D-mediated immunogene therapy of experimental gliomas.
Friese, M. A., Platten, M., Lutz, S. Z., Naumann, U., Aulwurm, S., Bischof, F., Bühring, H. ‐., DICHGANS, J., Rammensee, H., Steinle, A., et al. (2003) · PubMed · Cited by 193
Venkataraman, G. M., Suciu, D., Groh, V., Boss, J. M., & Spies, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.961 · Cited by 191
Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways
Coudert, J. D., Scarpellino, L., Gros, F., Vivier, E., & Held, W. (2008) · Blood · doi:10.1182/blood-2007-07-100057 · Cited by 185
Girardi, M., Glusac, E., Filler, R. B., Roberts, S. J., Propperova, I., Lewis, J., Tigelaar, R. E., & Hayday, A. C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021282 · Cited by 185
TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis
Finnberg, N., Klein-Szanto, A. J. P., & El-Deiry, W. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci29900 · Cited by 180
Krockenberger, M., Dombrowski, Y., Weidler, C., Ossadnik, M., Hönig, A., Häusler, S., Voigt, H., Becker, J. C., Leng, L., Steinle, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7338 · Cited by 179
Tumor and viral recognition by natural killer cells receptors
Arnon, T. I., Markel, G., & Mandelboim, O. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.005 · Cited by 178
ATM promotes apoptosis and suppresses tumorigenesis in response to Myc
Pusapati, R. V., Rounbehler, R. J., Hong, S., Powers, J. T., Yan, M., Kiguchi, K., McArthur, M. J., Wong, P. K. Y., & Johnson, D. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507367103 · Cited by 177
A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity
Diefenbach, A., Hsia, J. K., Hsiung, M. B., & Raulet, D. H. (2003) · European Journal of Immunology · doi:10.1002/immu.200310012 · Cited by 170
Self-citationNKG2D signaling is coupled to the interleukin 15 receptor signaling pathway
Horng, T., Bezbradica, J. S., & Medzhitov, R. (2007) · Nature Immunology · doi:10.1038/ni1524 · Cited by 168
Fas ligand–mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity
Groh, V., Smythe, K., Dai, Z., & Spies, T. (2006) · Nature Immunology · doi:10.1038/ni1350 · Cited by 167
Bloushtain, N., Qimron, U., Bar-Ilan, A., Hershkovitz, O., Gazit, R., Fima, E., Korc, M., Vlodavsky, I., Bovin, N. V., & Porgador, A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.4.2392 · Cited by 165
Enhanced In Vivo Growth of Lymphoma Tumors in the Absence of the NK-Activating Receptor NKp46/NCR1
Halfteck, G. G., Elboim, M., Gur, C., Achdout, H., Ghadially, H., & Mandelboim, O. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801878 · Cited by 162
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies
Zerafa, N., Westwood, J. A., Cretney, E., Mitchell, S., Waring, P., Iezzi, M., & Smyth, M. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.5586 · Cited by 159
Hayashi, T., Imai, K., Morishita, Y., Hayashi, I., Kusunoki, Y., & Nakachi, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2776 · Cited by 159
Tumor rejection by the poliovirus receptor family ligands of the DNAM-1 (CD226) receptor
Tahara‐Hanaoka, S., Shibuya, K., Kai, H., Miyamoto, A., Morikawa, Y., Ohkochi, N., Honda, S.-I., & Shibuya, A. (2005) · Blood · doi:10.1182/blood-2005-04-1684 · Cited by 152
Boles, K. S., Stepp, S. E., Bennett, M., Kumar, V., & Mathew, P. A. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810120.x · Cited by 151
Boutet, P., Agüera‐González, S., Atkinson, S. J., Pennington, C. J., Edwards, D. R., Murphy, G., Reyburn, H. T., & Valés‐Gómez, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.49 · Cited by 146
Liu, Z., Eltoum, I. A., Guo, B., Beck, B. H., Cloud, G. A., & Lopez, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6044 · Cited by 142
Characterization of inhibitory and stimulatory forms of the murine natural killer cell receptor 2B4.
Schatzle, J., Sheu, S., Stepp, S., Mathew, P., Bennett, M., & Kumar, V. (1999) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.96.7.3870 · Cited by 132
Type I natural killer T cells suppress tumors caused by p53 loss in mice
Swann, J. B., Uldrich, A. P., van Dommelen, S. L. H., Sharkey, J., Murray, W. K., Godfrey, D. I., & Smyth, M. J. (2009) · Blood · doi:10.1182/blood-2009-01-198564 · Cited by 126
Expression and function of NKG2D in CD4 + T cells specific for human cytomegalovirus
Sáez‐Borderías, A., Gumá, M., Angulo, A., Bellosillo, B., Pende, D., & López‐Botet, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200636682 · Cited by 112
Poggi, A. D., Catellani, S., Garuti, A., Pierri, I., Gobbi, M., & Zocchi, M. R. (2009) · Leukemia · doi:10.1038/leu.2008.354 · Cited by 109
Yadav, D., Ngolab, J., Lim, R. S.-H., Krishnamurthy, S. R., & Bui, J. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.39 · Cited by 108
Lilienfeld‐Toal, M. V., Nattermann, J., Feldmann, G., Sievers, E., Frank, S., Strehl, J., & Schmidt‐Wolf, I. G. H. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03078.x · Cited by 104
IFN-Dependent Down-Regulation of the NKG2D Ligand H60 on Tumors
Bui, J. D., Carayannopoulos, L. N., Lanier, L. L., Yokoyama, W. M., & Schreiber, R. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.905 · Cited by 104
Schwinn, N., Vokhminova, D., Sucker, A., Textor, S., Striegel, S., Moll, I., Nausch, N., Tuettenberg, J., Steinle, A., Cerwenka, A., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.24098 · Cited by 101
Nomura, M., Takihara, Y., & 島田, 和. (1994) · Differentiation · doi:10.1046/j.1432-0436.1994.5710039.x · Cited by 101
Whang, M. I., Guerra, N., & Raulet, D. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802439 · Cited by 100
Self-citationVaidya, S. V., Stepp, S. E., McNerney, M. E., Lee, J., Bennett, M., Lee, K., Stewart, C. L., Kumar, V., & Mathew, P. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.800 · Cited by 100
Molecular Basis of the Dual Functions of 2B4 (CD244)1
Chlewicki, L. K., Velikovsky, C., Balakrishnan, V., Mariuzza, R., & Kumar, V. (2008) · Journal of Immunology · doi:10.4049/jimmunol.180.12.8159 · Cited by 98
Posttranslational regulation of the NKG2D ligand Mult1 in response to cell stress
Nice, T. J., Coscoy, L., & Raulet, D. H. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20081335 · Cited by 97
Self-citationRecognition of a Ubiquitous Self Antigen by Prostate Cancer-Infiltrating CD8 + T Lymphocytes
Savage, P. A., Vosseller, K., Kang, C., Larimore, K., Riedel, E., Wojnoonski, K., Jungbluth, A. A., & Allison, J. P. (2008) · Science · doi:10.1126/science.1148886 · Cited by 93
Takada, A., Yoshida, S., Kajikawa, M., Miyatake, Y., Tomaru, U., Sakai, M., Chiba, H., Maenaka, K., Kohda, D., Fugo, K., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1678 · Cited by 91
Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
Unni, A. M., Bondar, T., & Medzhitov, R. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701675105 · Cited by 90
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo
Reimann, M., Loddenkemper, C., Rudolph, C., Schildhauer, I., Teichmann, B., Stein, H., Schlegelberger, B., Dörken, B., & Schmitt, C. A. (2007) · Blood · doi:10.1182/blood-2007-02-075614 · Cited by 88
Qin, Z., Kim, H. J., Hemme, J., & Blankenstein, T. J. F. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011887 · Cited by 79
Cerboni, C., Ardolino, M., Santoni, A., & Zingoni, A. (2009) · Blood · doi:10.1182/blood-2008-06-165944 · Cited by 67
A cancer immunosurveillance controversy
Qin, Z., & Blankenstein, T. J. F. (2003) · Nature Immunology · doi:10.1038/ni0104-3 · Cited by 66
Fassò, M., Waitz, R., Hou, Y., Rim, T., Greenberg, N. M., Shastri, N., Fong, L. H., & Allison, J. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712269105 · Cited by 58
Wu, J. D., Atteridge, C. L., Wang, X., Seya, T., & Plymate, S. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1305 · Cited by 55
Nausch, N., Florin, L., Hartenstein, B., Angel, P. E., Schorpp‐Kistner, M., & Cerwenka, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.7 · Cited by 54
DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor
Zhou, H., Luo, Y., Lo, J., Kaplan, C. D., Mizutani, M., Mizutani, N., Lee, J.-D., Primus, F. J., Becker, J. C., Xiang, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502208102 · Cited by 49
AID and RAG1 do not contribute to lymphomagenesis in Eμ c-myc transgenic mice
Nepal, R. M., Zaheen, A., Basit, W., Li, L., Berger, S. A., & Martín, A. (2008) · Oncogene · doi:10.1038/onc.2008.111 · Cited by 28
Azimi, N., Jacobson, S., Tanaka, Y., Corey, L., Groh, V., & Spies, T. A. (2006) · Immunogenetics · doi:10.1007/s00251-006-0082-9 · Cited by 24
Taneja, V., Taneja, N., Behrens, M. D., Griffiths, M. M., Luthra, H. S., & David, C. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1118 · Cited by 23
Cited by
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
Self-citationBöttcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., Rogers, N. C., Sahai, E., Zelenay, S., & Reis e Sousa, C. (2018) · Cell · doi:10.1016/j.cell.2018.01.004 · Cited by 1,857
Harnessing innate immunity in cancer therapy
Demaria, O., Cornen, S., Daëron, M., Morel, Y., Medzhitov, R., & Vivier, E. (2019) · Nature · doi:10.1038/s41586-019-1593-5 · Cited by 957
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Bonneville, M., O'Brien, R. L., & Born, W. K. (2010) · Nature Reviews Immunology · doi:10.1038/nri2781 · Cited by 952
Metadata
- Authors
- Raulet, D. H., & Guerra, N.
- Venue
- Nature Reviews Immunology
- Published
- 2009-08
- Volume
- 9
- Issue
- 8
- Pages
- 568-580
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2061262594
- Cited by
- 404
- References
- 146
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.